2 minutes to read
Starting January 1, 2024, Medicare introduced significant changes that directly impact Durable Medical Equipment (DME) and Home Medical Equipment (HME) providers. One notable update concerns the coverage of lymphedema compression treatment items for Medicare Part B patients. In this blog post, we’ll delve into the key aspects of this change and what it means for your business.
What’s Covered?
Medicare will now pay for both standard and custom-fitted lymphedema compression treatment items for each affected body part. This includes compression garments, bandaging systems, and gradient compression wraps with adjustable straps. Additionally, necessary accessories such as aids for donning and doffing, fillers, lining, padding, and zippers are covered.
Frequency of Coverage:
- Daytime: 3 garments per affected body part every 6 months.
- Nighttime: 2 garments per affected body part every 2 years.
Items may also be replaced as needed due to loss, theft, irreparable damage, or changes in the patient’s condition.
Eligibility and Prescribing:
To be eligible for coverage, patients must have Medicare Part B coverage and a prescription from an authorized practitioner. The coverage applies when the lymphedema compression items are used primarily and customarily to treat the condition.
Supplier Enrollment:
Providers must be enrolled as Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers to receive Medicare payment for furnishing these treatment items. If you are enrolling for the first time, a letter specifying your intent to supply lymphedema compression treatment items should be submitted with your application.
Responsibilities of Providers:
Providers are responsible for all aspects of providing the treatment items, including taking measurements, fitting services, patient training, and item maintenance. External fitters may be employed, but the ultimate responsibility lies with the enrolled DMEPOS supplier.
Billing Information:
Starting January 1, utilize the new and existing codes provided in the January 2024 Alpha-Numeric HCPCS File.
Where to Find More Information:
For further details, refer to the Final Rule, Section 4133 of the Consolidated Appropriations Act (CAA), and Section 1834(j) of the Act.
In conclusion, these updates signify a positive step towards improved coverage and support for patients dealing with lymphedema. As DME/HME business owners, it is crucial to familiarize yourselves with these changes, ensuring seamless integration into your services.
Related Articles